M&As: Buy-Side Transactions

The Buy-Side M&A Process

When advising a buyer, the investment bank helps evaluate targets, structure bids, and execute the acquisition.

Pre-Bid Analysis

• Strategic rationale: Why acquire? Revenue synergies, cost synergies, market share, technology, talent, geographic expansion
• Target valuation: Comparable company analysis, precedent transactions, DCF, and LBO analysis to determine the maximum price
• Pro forma modeling: Combined entity financials — is the deal accretive or dilutive to the buyer's EPS?
• Impediment analysis: Identify obstacles — shareholder rights plans (poison pills), staggered boards, control share acquisition statutes, supermajority voting requirements
• Financing plan: Cash on hand, new debt, equity issuance, or combination — evaluate credit implications

LBO (Leveraged Buyout) Analysis

Used primarily by private equity firms. The LBO model calculates the maximum purchase price that allows the sponsor to achieve a target IRR (typically 20%+) given a specific capital structure (high leverage) and exit timeline (3–7 years).

Anti-Takeover Defenses

The exam expects you to recognize common defenses:

• Poison pill (shareholder rights plan): Allows existing shareholders to purchase additional shares at a discount if an acquirer crosses a threshold (typically 15–20%), diluting the acquirer's stake
• Staggered board: Only a portion of directors are up for election each year, making it harder to gain board control quickly
• White knight: A friendly acquirer is invited to make a competing bid
• Crown jewel defense: Selling key assets to make the target less attractive
• Golden parachute: Generous severance for executives triggered by a change of control — increases acquisition cost

Pro Forma Analysis and Synergies

After modeling the acquisition, bankers prepare pro forma financials showing the combined entity:

• Revenue synergies: Cross-selling, expanded distribution, pricing power — harder to quantify, realized slowly
• Cost synergies: Headcount reduction, facility consolidation, procurement savings, duplicate system elimination — easier to quantify, realized faster
• Financial synergies: Tax benefits, lower cost of capital, improved credit profile

Accretion/dilution test: Compare the buyer's standalone EPS to the combined pro forma EPS. If pro forma EPS is higher → accretive. If lower → dilutive. Key factors:

• Payment method (cash, stock, or mix)
• Target's P/E vs. buyer's P/E
• Financing costs (interest on acquisition debt)
• Synergies included in the model

Additional Anti-Takeover Impediments

Beyond the well-known defenses (poison pills, staggered boards), the FINRA outline lists several structural impediments that bankers must identify during buy-side analysis:

• Control share acquisition statutes: State laws (adopted in over 25 states) that strip voting rights from shares acquired above certain thresholds (typically 20%, 33%, 50%) unless the remaining disinterested shareholders approve restoring voting rights. This can effectively block a hostile acquisition even after the buyer has purchased a large stake.
• Supermajority voting requirements: Charter provisions requiring more than a simple majority (e.g., 67% or 80%) to approve mergers, amendments, or removal of directors. Makes hostile takeovers much harder because the acquirer needs far more than 50%+1 of the vote.
• Fair price provisions: Charter amendments requiring that any acquirer pay ALL shareholders the same price — typically the highest price paid for any shares in the preceding period. Prevents two-tier tender offers (front-end loaded bids where the first shareholders to tender get a premium).
• Blank-check preferred stock: Authorized but unissued preferred stock that the board can issue at any time with any terms — can be quickly deployed as a poison pill or to dilute a hostile bidder.

Accretion/Dilution — The Two Core Frameworks

The existing course introduces the P/E rule for all-stock deals. In practice, bankers use two different frameworks depending on how the deal is financed, and the Series 79 tests both.

Framework 1: P/E Rule (All-Stock Deals)

In an all-stock deal with no premium and no synergies, the direction of accretion or dilution depends on the relationship between the acquirer's P/E and the target's effective purchase P/E:

• Buyer P/E > target effective purchase P/E → accretive
• Buyer P/E < target effective purchase P/E → dilutive
• Buyer P/E = target effective purchase P/E → neutral

A control premium raises the effective purchase P/E. If target standalone P/E is 14.0x and buyer pays a 40% premium, the effective purchase P/E is 14.0 × 1.40 ≈ 19.6x. A 18.0x acquirer paying that premium would see dilution — even though its standalone P/E exceeds the target's standalone P/E. Students who skip the premium adjustment get this wrong.

Framework 2: Earnings Yield Test (All-Cash, Debt-Funded Deals)

For cash deals funded with new debt, the P/E rule doesn't directly apply. Instead, the deal is accretive when the target's earnings yield exceeds the acquirer's after-tax cost of debt:

• Target earnings yield = target net income ÷ purchase price
• After-tax cost of debt = pre-tax interest rate × (1 − tax rate)
• Earnings yield > after-tax cost of debt → accretive
• Earnings yield < after-tax cost of debt → dilutive

Worked example: Buyer finances a $1B acquisition with 6% pre-tax debt, 25% tax rate. After-tax cost = 6% × 0.75 = 4.5%. Target generates $60M of net income. Target earnings yield = $60M ÷ $1B = 6.0%. Since 6.0% > 4.5%, the deal is accretive before synergies. This test ignores step-up D&A, transaction expenses, and foregone interest — it's the starting screen, not the final answer.

Exchange Ratio Mechanics in Stock Deals

In a stock-for-stock transaction, the acquirer issues shares to target shareholders at a negotiated exchange ratio. How that ratio is structured determines who bears the risk of acquirer stock price movement between signing and closing.

Fixed Exchange Ratio

Each target share receives a fixed number of acquirer shares. If acquirer stock drops between signing and closing, the dollar value delivered falls — target shareholders bear the price risk. This structure is common when the acquirer wants to lock in pro forma ownership percentages and synergy math.

Floating Exchange Ratio

Each target share receives a fixed dollar value, with the exchange ratio adjusting based on acquirer stock price. If acquirer stock drops, more acquirer shares are issued to deliver the same dollar value — acquirer shareholders bear the dilution risk. This structure is common when the target insists on price certainty.

Collared Exchange Ratios

A compromise: the ratio is fixed within a band, then floats outside the band to limit extreme outcomes. A symmetric collar might fix the ratio if acquirer stock stays between $45 and $55, then float outside those boundaries.

Implied Premium Math

The implied offer price equals the exchange ratio times the acquirer's stock price. Implied premium equals implied offer price divided by the target's unaffected price, minus one.

• Example: 0.80 exchange ratio, acquirer stock $50, target unaffected price $30
• Implied offer price = 0.80 × $50 = $40 per target share
• Implied premium = ($40 ÷ $30) − 1 = 33.3%

Pro Forma Adjustments Beyond the Basics

A real A/D model incorporates adjustments the simplified P/E rule ignores. Each affects pro forma EPS and can flip the headline result.

Synergy Phasing

Synergies are modeled year by year, not realized instantly. A common convention is 0% realization in year 1 (integration costs dominate), 50% in year 2, and 100% run-rate by year 3. Headlines that quote "$200M of synergies" typically mean the run-rate number; year 1 accretion calculations may show zero contribution.

Revenue Synergy Probability Discount

Sophisticated acquirers discount announced revenue synergies — typically 50% or more — because cross-selling and pricing gains are notoriously uncertain. Cost synergies (headcount, facility consolidation, procurement) are easier to quantify and realize faster, so they carry less discount. Boards scrutinize models that fail to apply this haircut.

Foregone Interest on Cash Used

When the acquirer uses balance-sheet cash to fund a deal, the pro forma model adds back lost interest income, after tax. If $500M of cash earning 3% pre-tax is deployed at a 25% tax rate, the model loses $500M × 3% × 75% = $11.25M of net income annually. This reduces pro forma EPS before any deal-specific effects.

Step-Up D&A

In deals with tax basis step-up (asset purchases or §338(h)(10) elections), the acquirer gets a larger depreciable/amortizable base. The incremental D&A reduces pro forma net income — but because it's a tax-deductible non-cash charge, the net income impact is the incremental D&A times (1 − tax rate). Cash flow benefits from the tax shield; GAAP EPS suffers from the accrual charge.

Transaction Expenses — ASC 805

Under ASC 805, transaction-related costs are expensed as incurred, not capitalized. Investment banker success fees, legal fees, and accounting fees hit the P&L as period expenses, reducing pro forma net income in the year they're incurred. Financing fees (debt commitment fees, underwriting spreads on new debt) are generally capitalized against the debt issuance and amortized.

Minority Interest

If the target consolidates a subsidiary in which it owns less than 100%, consolidated net income includes earnings belonging to minority (non-controlling) shareholders. Those earnings are deducted from pro forma consolidated net income before computing EPS attributable to the acquirer's shareholders.

Dilutive Convertibles — If-Converted Method

If the target has convertible securities outstanding (convertible notes, convertible preferred), the A/D model must assume conversion where dilutive. Under the if-converted method, interest expense on the convertible is added back (net of tax) and the resulting converted shares are added to diluted share count. The result may be dilutive or antidilutive depending on the specifics.

LBO Returns — The Three IRR Drivers

Sponsor IRR in an LBO comes from three distinct sources. Understanding which driver contributed what is central to both investment committee review and exit planning.

Driver 1: EBITDA Growth

Operational improvements grow the target's EBITDA over the hold period. Revenue growth, margin expansion, pricing optimization, and bolt-on acquisitions all feed this bucket. This is the driver most directly within sponsor control and the one investment committees weigh most heavily when evaluating operational theses.

Driver 2: Multiple Expansion

If the sponsor buys at 8.0x EBITDA and exits at 10.0x EBITDA, that two-turn expansion adds to IRR independently of operational performance. Multiple expansion is largely market-driven — it reflects buyer appetite, interest rates, and sector sentiment at exit. Because it's outside sponsor control, committees typically demand underwriting that assumes flat or declining exit multiples, treating any expansion as upside.

Driver 3: Debt Paydown

Free cash flow generated during the hold period pays down acquisition debt. Because equity value equals enterprise value minus net debt, reducing debt directly increases equity value even if EBITDA and exit multiple are flat. This is sometimes called the "deleveraging tailwind."

Decomposition Example

Sponsor invests $400M equity in a $1,000M enterprise value deal (60% debt). Five years later, sale at $1,600M enterprise value, debt reduced to $400M, equity recovery $1,200M. MOIC = 3.0x, IRR ≈ 24.6%. Attribution might look like:

• EBITDA growth: EBITDA up 50% over hold — contributes ~10 points of IRR
• Multiple expansion: 8.0x → 8.5x — contributes ~4 points of IRR
• Debt paydown: $600M → $400M — contributes ~11 points of IRR

Sophisticated models attribute IRR across these three buckets; anything over-reliant on multiple expansion is treated with skepticism.

Sources and Uses — Sizing the Equity Check

The sources-and-uses table balances total cash required (uses) against funding sources. The sponsor equity check is the plug.

Uses of Funds

• Cash to sellers: equity purchase price
• Refinanced target debt: existing debt paid off at closing (recall: cash-free/debt-free convention means the buyer's quoted enterprise value does not include target debt)
• Transaction fees: M&A advisory, legal, accounting, DD (expensed under ASC 805)
• Financing fees: arrangement fees on new debt (capitalized and amortized)
• Minimum cash at close: working capital buffer for operations

Sources of Funds

• New term loans and bonds: sized to a leverage multiple (e.g., 5.5x EBITDA)
• Mezzanine financing: junior debt layer
• Sponsor equity: the equity check
• Rollover equity: existing management or sellers re-invest alongside the sponsor

Equity Check Math

Worked example: Enterprise value $800M. Target debt $150M (refinanced at close). Transaction and financing fees $30M. Minimum cash $10M. Total uses = $800M + $150M + $30M + $10M = $990M.

New debt financing = $500M. Management rollover equity = $40M. Sponsor equity check = $990M − $500M − $40M = $450M.

Management Rollover Equity

Rollover lets management re-invest a portion of sale proceeds into the new company, often through a Section 351 tax-deferred exchange. Benefits:

• Sponsor: smaller equity check, stronger alignment with the team running the business
• Management: defer tax on rolled-over proceeds, participate in future upside, signal commitment

Ownership math after rollover: management's % of new equity equals rollover ÷ (sponsor equity + rollover equity). In the example above, $40M ÷ ($450M + $40M) ≈ 8.2%.

Cash-Free / Debt-Free Convention

When a purchase is quoted on a CF/DF basis, the enterprise value ignores the target's cash and debt. Target cash at close reduces the equity purchase price (acquirer effectively receives it). Target debt at close is refinanced or assumed, funded as a separate use. Working capital adjustments then true up any variance from the negotiated working capital target post-closing.

LBO Capital Structure — Tranche Priority

An LBO typically layers multiple debt tranches above the sponsor equity. Priority at bankruptcy, pricing, covenants, and security packages differ at each level.

Priority Waterfall (Senior to Junior)

1. Revolver (R/C): secured, funded as needed for working capital; typically first-lien on collateral
2. First-lien term loan (TLB): secured, typically the largest tranche, floating-rate
3. Second-lien term loan: secured but subordinated to first-lien in enforcement
4. Senior unsecured notes: fixed-rate, no security, senior in payment priority to subordinated debt
5. Subordinated / mezzanine notes: contractually subordinated; often cash + PIK interest; sometimes with warrants
6. Preferred equity: hybrid, above common in liquidation
7. Common equity: sponsor + rollover, residual claim

Unitranche

Common in middle-market LBOs: a single debt facility combining first- and second-lien economics into one blended rate, typically provided by a direct lender. Simplifies the capital structure and the intercreditor relationship — both at the cost of a higher blended coupon.

Mezzanine Financing

Subordinated debt layer between senior debt and equity. Key features:

• Cash interest plus PIK: e.g., 8% cash and 4% PIK (paid-in-kind, accrues to principal)
• Warrants or equity co-investment: often included, giving the mezz lender equity-like upside
• Looser covenants than senior debt, but higher coupon reflecting subordination

Intercreditor Agreements

Where multiple secured tranches exist, the intercreditor agreement governs who gets paid first from collateral proceeds, who controls enforcement actions (which lien-holder can foreclose), who can block restructurings, and who can provide DIP financing in bankruptcy. These provisions materially affect recovery math in a downside scenario.

LBO Covenants and Deal Financing

Maintenance vs. Incurrence Covenants

Covenants are the lender's ongoing risk controls on the borrower.

• Maintenance covenants (common in bank debt) must be met quarterly regardless of borrower action. Example: net debt / EBITDA ≤ 5.5x tested each quarter. A breach triggers default even without any corporate activity by the borrower.
• Incurrence covenants (common in bonds) only trigger when the borrower takes specified actions — incurring additional debt, paying dividends, making investments, etc. If the borrower sits still, no breach.

Covenant-Lite

Large-cap LBO term loans are increasingly covenant-lite ("cov-lite") — structured like bonds with incurrence-only covenants. Cov-lite structures favor borrowers; they reduce the risk of technical default during temporary EBITDA softness. Lenders accept cov-lite in exchange for higher spreads or because market demand allows it.

Equity Cure Rights

Some LBO credit agreements let the sponsor cure a maintenance covenant breach by contributing additional equity, which is added back to EBITDA for covenant testing purposes. Standard limits:

• Typically 2–3 cures per loan life (often "no consecutive quarters")
• Cure amount is limited to what's needed to cure (not a free add-back)

Debt Commitment Letters and "Certain Funds"

At signing, the sponsor secures a debt commitment letter from lead arrangers. The commitment is subject only to limited conditions — the "SunGard" or "certain funds" conditions — so the seller has confidence the financing will be there at close. These conditions are market-standard and narrow: absence of target MAE, accuracy of specified reps, execution of the merger agreement.

Bridge Loans

For bond-financed deals, lenders commit bridge loans that will be taken out by permanent bond issuance. The bridge exists so the sponsor isn't dependent on bond market conditions at close — if the high-yield market seizes up, the bridge funds. Bridges typically carry step-up pricing that incentivizes the sponsor to syndicate bonds quickly.

Reverse Termination Fees (RTF)

If the sponsor cannot close because its financing fails, the seller's remedy is typically a reverse termination fee, paid in cash. Market ranges 3–8% of equity value. The RTF caps sponsor exposure and, in most sponsor deals, is the sole and exclusive remedy for financing failure (see conditional specific performance below).

Conditional Specific Performance

Sophisticated sellers negotiate conditional specific performance: the seller can force closing through specific performance only if debt financing is available. If financing has failed, specific performance is unavailable, and the seller is limited to the RTF. This bifurcation ensures the sponsor can't pretextually walk when financing is actually available (seller can force close), while still protecting the sponsor against catastrophic exposure if financing genuinely fails.

Stock Purchase vs. Asset Purchase — Tax Trade-offs

Buyer and seller have diametrically opposed tax preferences on deal structure. The outcome is typically negotiated through purchase price adjustments.

Buyer Preference: Asset Purchase

In a taxable asset purchase, the buyer allocates the purchase price across acquired assets, creating a stepped-up tax basis. Stepped-up basis generates:

• New depreciation on acquired PP&E (tangible assets)
• New amortization on acquired intangibles including goodwill — Section 197 allows 15-year straight-line amortization of goodwill for tax purposes
• Future tax shields that lower effective tax rate for years post-close

Seller Preference: Stock Purchase

In a taxable stock sale, the seller is typically preferred:

• C-corporation target: A direct stock sale produces one level of tax (seller capital gains). An asset sale produces two levels — corporate tax on the asset sale gain, then shareholder tax on the liquidating distribution
• S-corporation or partnership target: Pass-through treatment removes the double-tax friction, making asset and stock deals roughly equivalent at the seller level

Goodwill Tax Treatment — The Asymmetry

This is a frequent exam point:

• Taxable asset deal: goodwill is tax-deductible (§197, 15-year amortization)
• Taxable stock deal without §338 election: goodwill is not tax-deductible at the target level — the target's historical tax basis is preserved

This asymmetry makes asset deals materially more valuable to the buyer on an after-tax basis. Buyers quantify the differential and typically offer sellers a gross-up payment to compensate for the higher tax bill the seller incurs by doing an asset deal — effectively sharing the tax shield benefit.

Non-Tax Considerations

Beyond tax, structure affects:

• Liability transfer: asset deals let the buyer leave known and unknown liabilities with the seller; stock deals transfer all liabilities
• Third-party consents: asset deals often require more consents (contracts, licenses, permits) because they're assigned rather than carried along with the entity
• Minority shareholder treatment: asset deals avoid squeeze-out mechanics; stock deals may require statutory procedures to capture holdouts

Section 338 Elections — Getting Asset Treatment on a Stock Deal

Section 338 of the Internal Revenue Code allows the tax treatment of a stock purchase to be recharacterized as a deemed asset sale. Three variants exist, each with different eligibility rules.

Section 338(h)(10) — The Workhorse

A joint buyer-and-seller election that treats the stock purchase as a deemed asset sale for tax purposes:

• Buyer gets stepped-up basis in target assets (same benefit as an actual asset purchase)
• Seller recognizes gain as if assets were sold — can be disadvantageous vs. a pure stock sale
• Joint election — every selling shareholder must sign the election form
• Buyer typically pays seller a gross-up to compensate for the seller's incremental tax cost

§338(h)(10) Eligibility — This Is the Exam Trap

§338(h)(10) is available only for specific target types:

• S-corporation targets
• Targets that are subsidiaries in a U.S. consolidated tax group (parent sells the sub)
• Certain affiliated group transactions

§338(h)(10) is NOT available for freestanding publicly-traded C-corporations with diffuse shareholders. This is a common exam question: when a buyer wants asset treatment on a public-company stock deal, §338(h)(10) is simply not on the menu.

Section 338(g) — Unilateral Buyer Election

A buyer-only election requiring no seller consent:

• Tax cost of the deemed asset sale is borne by the target itself, not the seller
• Primarily useful for foreign target acquisitions, where the deemed-sale gain may fall outside U.S. taxing jurisdiction
• Rarely elected for domestic targets because the target-level tax cost usually outweighs the buyer's step-up benefit

Section 336(e) — Broader Eligibility Cousin

Section 336(e) operates like §338(h)(10) but reaches some transactions §338(h)(10) does not:

• Applies to certain transactions with individual or partnership sellers (not just corporate sellers)
• Distribution-style transactions (including some spin-offs followed by sales)

§336(e) has become increasingly important in structuring mid-market deals involving private company sellers who don't fit §338(h)(10)'s eligibility box.

Merger Structures — Forward, Forward Triangular, Reverse Triangular

The legal structure of a merger affects contract assignment, tax treatment, and whether the target entity survives closing.

Forward (Direct) Merger

The target is merged directly into the buyer. The buyer survives; the target entity ceases to exist. Target contracts are assigned to the buyer by operation of law. Some contracts contain anti-assignment clauses that trigger on this assignment — leading to consent requirements or lost rights.

Forward Triangular Merger

The target is merged into a buyer subsidiary (often created for the deal). The subsidiary survives with the target's assets and business; the target entity ceases to exist. Assignment issues still apply because the target entity disappears.

Reverse Triangular Merger — The Contract-Preserving Structure

A buyer subsidiary is merged into the target. The target entity survives — now as a wholly-owned subsidiary of the buyer. Because the target entity continues to exist, contracts, licenses, permits, and third-party agreements remain with the target by operation of law without assignment. This structure is preferred when the target holds assignment-sensitive contracts, regulatory licenses, or permits that are difficult to transfer.

Tax-Free Reorganizations — Section 368

Mergers can qualify for tax-free treatment under Section 368 if structural and policy requirements are met. The three principal forms:

• Type A: statutory merger or consolidation under state law. Flexible on consideration mix; permits cash plus stock within the "continuity of interest" requirement
• Type B: stock-for-stock acquisition. Buyer acquires 80%+ of the target's voting stock solely for buyer voting stock (no cash component permitted)
• Type C: stock-for-assets acquisition. Buyer acquires substantially all of the target's assets solely for buyer voting stock

Two Overarching §368 Requirements

• Continuity of interest (COI): target shareholders must receive a substantial equity stake in the surviving entity. The IRS generally wants 40%+ of consideration to be buyer stock. Cash-heavy deals fail COI and don't qualify for §368 treatment
• Continuity of business enterprise (COBE): the surviving entity must continue the target's historic business or use a significant portion of its historic assets. Pure asset-strip transactions fail COBE

When both requirements and the specific Type A/B/C mechanics are met, target shareholders defer taxation on the stock portion of consideration received. Cash portions remain taxable.

Section 280G — Golden Parachute Payments

When a change-in-control triggers payments to target executives, Section 280G imposes tax penalties on "excess parachute payments." The framework catches many deals in diligence.

The Trigger

§280G applies when change-in-control payments to a "disqualified individual" (typically officers, directors, highly-compensated employees) total three times or more of the executive's base amount. The base amount is the individual's average W-2 compensation over the five tax years preceding the change in control.

What Counts as a Parachute Payment

• Cash severance
• Accelerated vesting of equity awards (restricted stock, RSUs, options)
• Change-in-control bonuses ("single-trigger" payments)
• Tax gross-ups and continued benefits

Consequences at Two Levels

Once the 3× trigger is met, the "excess parachute payment" — the portion above 1× base amount — carries tax penalties at both levels:

• Corporate level: the employer loses its tax deduction on the excess portion (treated as non-deductible compensation)
• Executive level: the individual pays a 20% excise tax on the excess portion, in addition to ordinary income tax

Private-Company Cleansing Vote

Private companies have an important exception: a cleansing shareholder vote can neutralize §280G consequences. Requirements:

• More than 75% of the voting power (disregarding the disqualified individual's own shares) approves the payments
• Before the change in control
• After adequate disclosure of the material facts

The cleansing vote is NOT available for public companies, where §280G penalties must be managed through plan design (caps, cutbacks, gross-ups) rather than shareholder approval.

Practical Impact on Deal Planning

Parachute exposure is routinely modeled during diligence. Severance plans, equity vesting schedules, and employment agreements are stress-tested against the 3× trigger. Buyers often require sellers to obtain cleansing votes (where available) or to absorb the tax friction in the purchase price adjustment.

Due Diligence — The Workstream Framework

Due diligence on a buy-side transaction is not a single activity — it's a coordinated set of parallel workstreams, each staffed by specialists and each responsible for a defined scope. The banker's role is to coordinate these workstreams, synthesize findings, and translate them into bid strategy and deal terms.

Standard Workstreams

• Financial DD: led by a Big 4 or specialty accounting firm (outside buyer staff); produces a Quality of Earnings (QoE) report and working capital analysis
• Legal DD: led by outside counsel; covers corporate records, material contracts, litigation, IP, employment, real estate, regulatory matters
• Commercial DD: led by consultants (Bain, BCG, LEK, specialty firms); covers market sizing, competitive positioning, customer concentration, growth drivers
• Operational DD: supply chain, manufacturing, distribution, operational KPIs
• Tax DD: led by tax advisors; covers historical tax positions, exposures, §280G parachute analysis, §382 NOL analysis, state and local tax
• HR/Benefits DD: compensation programs, pension obligations, union relationships, executive severance exposure
• IT/Cybersecurity DD: technology infrastructure, security posture, breach history, software licenses
• Environmental DD: Phase I site assessments, remediation obligations, regulatory compliance

Timeline Phasing

DD is not a single event. It phases across the deal timeline:

• Preliminary DD (IOI round): public filings, teaser review, limited management interaction — enough to form an indication of interest but not confirmatory
• Access DD (LOI round): VDR opens, full management presentations, initial specialist work — enough to submit a binding bid
• Confirmatory DD (post-exclusivity): deep-dive specialist work, expert sessions, site visits, customer interviews — confirms the bid thesis and surfaces red flags that may chip price or shape deal terms
• Closing DD: bring-down of findings through signing-to-closing period, ordinary-course monitoring

The deepest and most expensive DD happens after exclusivity, when the buyer has the protected runway to invest in full specialist workstreams.

Quality of Earnings — The Most Consequential DD Report

The QoE report scrubs the target's reported financials to arrive at a normalized, repeatable EBITDA figure that the buyer can use as the baseline for its purchase price. More deals get repriced or broken in the QoE than in any other DD workstream.

Core Purpose

Reported EBITDA is often noisy: one-time items, acquisitions completed mid-year, aggressive revenue recognition, capitalized items that should be expensed, or owner-friendly add-backs. QoE produces an Adjusted EBITDA number that the buyer treats as the anchor for valuation discussions.

Run-Rate Adjustments

If the target acquired another business partway through the year, reported EBITDA contains only a partial-year contribution. QoE annualizes the acquired business's run-rate EBITDA to show what the combined business will produce in a full year. The same logic applies to new facility openings, product launches, and pricing changes that took effect mid-period.

Add-Backs — Legitimate vs. Aggressive

Sellers submit EBITDA add-backs intended to remove non-recurring or non-business expenses. The buyer's QoE provider evaluates each:

• Legitimate add-backs: genuinely one-time legal settlements, transaction costs for the current sale process, owner compensation above market for the role, clearly identified restructuring costs that have concluded
• Aggressive add-backs: "discretionary" marketing spend that actually drives revenue, owner compensation that understates the cost of replacing the owner, normal-course legal reserves, recurring restructuring labeled as one-time

The QoE report's Adjusted EBITDA typically strips many of the seller's submitted add-backs. Negotiation between the QoE provider and the seller's management is normal and expected.

Working Capital Normalization

QoE evaluates the target's working capital pattern to establish what "normal" looks like — this drives both the target working capital figure in the definitive agreement and identifies any working capital manipulation ahead of close (e.g., accelerating collections or stretching payables to juice closing-date cash).

Revenue Recognition Review

QoE examines revenue recognition practices: channel stuffing at period ends, bill-and-hold arrangements, aggressive percentage-of- completion estimates, and treatment of upfront fees under ASC 606. Revenue recognition issues that inflate EBITDA can produce large purchase-price adjustments once corrected.

Legal Due Diligence Scope

Legal DD is scoped and executed by outside counsel retained by the buyer. Its core output is a written DD report organized by subject- matter area, plus a disclosure schedule review for the definitive agreement.

Corporate Records

Verification of corporate existence, organizational documents, cap table accuracy, authority to enter the transaction, minute book completeness, and any outstanding preferred or convertible securities. Problems here can block the transaction — e.g., if the target can't demonstrate clean title to its shares, the seller can't deliver them.

Material Contracts

• Change-of-control provisions: contracts that terminate automatically, require counterparty consent, or trigger payment obligations upon the transaction
• Anti-assignment clauses: prohibit or condition transfer of the contract, relevant in asset deals and in mergers where target entity disappears (direct or forward triangular)
• Most-favored-nation clauses: may trigger repricing obligations across other customer contracts
• Exclusivity provisions: may restrict the combined company from expanding product lines or serving adjacent markets

Litigation and Regulatory Proceedings

All pending litigation — plaintiff and defendant side — plus threatened matters, governmental investigations, and regulatory enforcement actions. Specific indemnities are commonly negotiated for identified matters of material potential exposure.

Intellectual Property

• Ownership verification: all core IP actually owned by the target entity (not a founder personally, not a separate entity)
• Freedom to operate: the target's products don't infringe third-party rights
• Open-source license audit: software subject to copyleft licenses (GPL, AGPL) that may require source-code disclosure for commercial products
• Trademark and patent portfolio: status of registrations, pending prosecutions, licensing agreements

Employment Matters

Key-person agreements, non-compete enforceability (variable by state), labor union relationships and collective bargaining agreements, pending employment claims, executive severance exposure under §280G, and worker classification reviews (employee vs. contractor).

Real Estate, Permits, Licenses

Leased and owned property inventory, title work, environmental restrictions on use, regulatory licenses needed to operate. In regulated industries, license transferability is often dispositive on structure choice between direct merger (loses the license) and reverse triangular (preserves it).

Commercial DD and Specialist Workstreams

Commercial Due Diligence

Commercial DD tests the market thesis underlying the acquisition: is the target's addressable market real, growing, and defensible? Typical components:

• Market sizing and growth: independent analyst estimates, bottom-up build from customer segments, triangulated against the target's own projections
• Competitive positioning: market share, differentiation, moat analysis, win/loss dynamics
• Customer concentration: revenue by top 10 customers; customers representing 10%+ of revenue individually receive special scrutiny because loss of a single account would materially impact the business
• Customer interviews: typically "blinded" (target name not disclosed) and conducted through a third-party consultant to elicit candid feedback. Common in auction processes where sellers resist buyer-direct customer contact
• Supplier interviews: parallel structure for supply-chain-critical relationships

Phase I Environmental Site Assessment

The ASTM E1527-21 standard governs Phase I ESAs. The assessment is a records-and-observation review of each target property to identify recognized environmental conditions (RECs) — indications of past or present contamination, regulated substances, underground storage tanks, or neighboring facilities that may have migrated contamination onto the property.

Phase I identifies conditions; it does not sample or confirm. If Phase I identifies a REC, a Phase II ESA involves actual soil and groundwater sampling. Environmental liabilities from identified RECs typically flow to a special indemnity with dedicated escrow — not the general indemnity pool.

Cybersecurity DD

Standard scope includes breach history (including breaches that never became public), access control posture, data handling and encryption practices, vendor-risk exposure (third-party access to target data), and incident response readiness. Cybersecurity findings increasingly trigger special indemnities, cyber insurance requirements, or carve-outs from general reps.

HR/Benefits DD

• Pension obligations: defined-benefit plans — are they adequately funded, and what is the underfunded amount? Unfunded pension liabilities are typically classified as debt-like items in the purchase price bridge
• Executive compensation waterfalls: modeling change-in-control payments for §280G compliance, identifying disqualified individuals
• Post-retirement benefits: retiree medical obligations can be significant; often also debt-like items
• Collective bargaining agreements: union relationships, upcoming negotiation cycles, grievance history

Tech/IT DD

For tech-heavy targets (SaaS, marketplaces, tech-enabled services), a dedicated tech DD workstream reviews architecture, scalability, technical debt, engineering team retention, and development practices. Findings often drive integration planning and influence key-person retention packages.

Due Diligence Process Mechanics

The Virtual Data Room (VDR)

The VDR is the structured online repository where the seller makes diligence materials available to bidders. Standard platforms (Intralinks, Datasite, iDeals, Firmex) support detailed access controls, activity tracking, and tiered document release.

• Standard folder taxonomy: corporate records, financials, contracts, legal, IP, HR, real estate, environmental, regulatory, tax, technology, and miscellaneous
• Tiered release: sensitive documents (customer contracts with pricing, key employee compensation, proprietary financial models) are released only to final-round or exclusive bidders
• Tracking: VDR activity logs track which documents each bidder has opened and how long they spent — sellers use this to gauge bidder seriousness

Q&A Protocol

In auction processes, all bidder questions are funneled through the seller's financial advisor into a structured Q&A log. Key features:

• Questions and answers are typically made available to all bidders to prevent information asymmetry
• This structure discourages bidders from asking revealing questions that signal their thesis to competitors
• Sophisticated bidders ask generic foundational questions publicly and save targeted questions for exclusivity

Expert Sessions and Management Presentations

As the process advances, sellers host deep-dive sessions with specific management team members (CFO sessions on financials, CTO sessions on technology, VP-Sales sessions on pipeline). These are often the best opportunities for bidders to stress-test the data room picture directly with the people responsible.

Site Visits and Plant Tours

For operational businesses, physical site visits are essential. Sellers often limit these to final-round bidders to avoid disrupting target operations with repeated tours. Production tours, warehouse walk-throughs, and meetings with local management provide context that documents cannot.

DD Report Deliverables

Each workstream produces a written DD report organized around: findings, key risks, recommended remedies, and open items. These reports become core input to the buyer's investment committee materials and shape bid strategy, price adjustments, and definitive agreement negotiations.

Definitive Agreement — Purchase Price Mechanics

The purchase price section of a definitive agreement rarely consists of a single headline number. It's a calculation framework with multiple adjustments between signing and final settlement.

EV-to-Equity Bridge (Cash-Free / Debt-Free)

When a deal is quoted on a CF/DF basis, the headline enterprise value assumes the target will be delivered with no cash and no debt. The bridge from quoted EV to actual equity consideration:

• Start: quoted enterprise value
• Subtract: target debt at close (to be refinanced or assumed)
• Add: target cash at close (passes to buyer)
• Subtract or add: working capital true-up vs. negotiated target
• Subtract: any debt-like items classified as debt by the DA
• Equals: cash consideration to selling shareholders

Worked example: $500M quoted EV on CF/DF basis, target carries $80M debt and $20M cash at close, no working capital variance, no debt-like items. Cash to sellers = $500M − $80M + $20M = $440M.

Working Capital True-Up

The DA specifies a target working capital ("peg") — typically the trailing 12-month average of normalized operating working capital. At close:

• Actual working capital is estimated and captured as of closing
• If actual exceeds peg, the buyer pays the seller the difference (seller delivered more working capital than expected)
• If actual falls short of peg, the seller refunds the buyer the difference
• Often capped with a collar — e.g., ±$2M — to eliminate nuisance adjustments and reduce dispute exposure
• Final true-up occurs 60–120 days post-close after actual working capital is verified

Debt-Like Items

Not every balance sheet obligation is "debt" in the banker sense, but the DA may classify certain items as debt-like — reducing purchase price as if they were funded debt. Common debt-like items:

• Unfunded pension and OPEB obligations
• Deferred compensation liabilities
• Long-term accrued bonuses that have crystallized
• Certain tax reserves for identified exposures
• Customer deposits or prepayments that will need to be serviced
• Earn-out or contingent consideration from prior acquisitions

Classification is heavily negotiated. Buyers push for broader definitions (reduces price); sellers push for narrower ones (preserves price).

Escrow and Holdback Structures

A portion of purchase price is commonly held back to secure indemnification obligations:

• Escrow: held by a third-party escrow agent, released per DA terms (typically a portion at 12-month survival, remainder at 18- or 24-month general rep expiration)
• Holdback: retained by the buyer directly, with similar release schedule
• Sizing: historically 10% of purchase price; dropped significantly in the R&W insurance era (often 0.5–1% of deal value as a working capital and indemnity floor)
• Special indemnity escrows: larger, dedicated amounts for specific identified matters, separate from the general escrow

Representations and Warranties Framework

Reps and warranties are contractual statements by the seller (and sometimes the buyer) about the target's business as of signing and closing. They are the contract's primary risk-allocation device: if a rep is breached and the buyer suffers damages, the buyer has a post-closing claim against the seller or the R&W insurer.

Not a Diligence Substitute

Reps don't replace diligence — they complement it. A well-diligenced buyer uses reps to backstop issues diligence might miss, not to skip diligence in favor of contractual remedies. Claims on reps typically require the buyer to prove the rep was false and that damages flowed from the falsity.

Fundamental vs. General Reps

Reps divide into two tiers with different contractual treatment:

• Fundamental reps: corporate existence, authority to sell, title to shares, capitalization, broker fees. These are existential to the transaction. Typical survival: forever, indefinite, or through statute of limitations. Typical cap: purchase price or uncapped
• General reps: financial statements, contracts, litigation, compliance with laws, employee matters, operations. These are the business-operation reps. Typical survival: 12–24 months post-closing. Typical cap: 10–20% of purchase price
• Tax reps: often get their own survival period, running through the applicable statute of limitations (typically 3–7 years depending on jurisdiction and tax type)

Fraud carve-out: claims based on seller fraud are carved out of survival periods, caps, and baskets. Fraud claims survive indefinitely and are uncapped — regardless of what the DA says elsewhere.

Survival — The Deadline That Extinguishes Claims

Survival periods are notification deadlines. The buyer must notify the seller of a claim before the survival period expires, or the claim is extinguished. Survival is strictly enforced:

• A $25M rep breach discovered 19 months post-closing, when general reps carry 18-month survival, is unrecoverable
• The notice must typically be written, specific, and made to the addresses specified in the DA
• "Placeholder" notices (vague early warnings to preserve rights) are contractually disfavored but still used

Baskets — Tipping vs. Deductible

Baskets function like insurance deductibles but with two distinct mechanical variants:

• Deductible basket: the buyer recovers only losses in excess of the basket. A $2M deductible basket means losses of $5M recover $3M (the $2M is permanently absorbed by the buyer). Seller-favorable
• Tipping basket: once the basket threshold is crossed, the buyer recovers all losses from dollar one. A $2M tipping basket means losses of $5M recover the full $5M (the threshold "tipped"). Buyer-favorable
• Combined structures: some DAs use a tipping basket for most reps but a deductible for specified categories
• Mini-baskets ("de minimis"): individual claims below a threshold (e.g., $50,000) don't count toward the basket at all, filtering nuisance claims

Caps — The Maximum Recovery

General indemnity claims are capped at a specified percentage of purchase price — historically 10–20%, often lower when R&W insurance is in place. Fundamental reps are typically uncapped or capped at full purchase price. Seller fraud is always uncapped.

Representations and Warranties Insurance

R&W insurance has shifted from a niche product to a market standard on most middle-market and upper-middle-market deals. The product transfers indemnification risk from the seller to a third-party insurer.

Policy Mechanics

• Policy limit: the maximum coverage, typically sized at 10% of enterprise value (sometimes less, sometimes more depending on deal dynamics)
• Retention (deductible): the insured bears the first layer of loss before coverage attaches. Retentions typically 0.5–1.0% of enterprise value, stepped down over time (e.g., 1.0% for 12 months, 0.5% thereafter)
• Premium: typically 2–4% of policy limits, paid one-time at placement. Premium scales with perceived risk, industry, and deal complexity
• Policy period: matches or extends beyond DA survival (often 6 years for tax reps, 3 years for general reps)

Buy-Side vs. Sell-Side Policies

Buy-side policies dominate the current market. Why:

• Clean exit for seller: seller walks away with minimal residual indemnification exposure — particularly valuable for private equity sellers winding down funds
• Simpler for buyer: the buyer collects directly from the insurer rather than pursuing the seller, avoiding litigation friction and collection risk
• Structural compatibility: works naturally with "insurance-first" indemnification structures where claims go to the insurer, with minimal seller backstop

Sell-side policies exist but are much rarer; they pay the seller for indemnification obligations the seller incurs to the buyer, essentially providing the seller with defense and indemnity coverage.

Standard Exclusions

R&W insurance does not cover everything reps cover:

• Known matters: issues disclosed in the VDR, DD reports, or disclosure schedules. Coverage only extends to unknown breaches. This is why diligence thoroughness matters even with insurance
• Seller fraud: the seller remains liable directly; insurance doesn't replace the fraud remedy
• Forward-looking statements: projections, estimates, future performance — these aren't reps in the traditional sense
• Purchase price adjustments: working capital true-ups and similar mechanical adjustments are outside scope
• Specific carve-outs: commonly include pension underfunding, FCPA, certain environmental matters, and jurisdictional tax matters in high-risk countries

Market Shift — Replacing Escrow

Before R&W insurance became standard, general indemnities were secured through 10%-of-purchase-price escrows. Today, on deals with R&W insurance, escrows are typically dropped to working capital true-up amounts only (0.5–1.0% of purchase price). The insurance sits above the retention and absorbs losses that would previously have drawn on escrow. This is part of why private-equity sellers disproportionately favor the structure.

MAE Clauses and Closing Conditions

Between signing and closing, the buyer is at risk: the business might deteriorate, regulatory approvals might not materialize, or fundamental assumptions might change. Closing conditions and the material adverse effect (MAE) clause allocate these risks.

Standard Closing Conditions

Buyer obligations to close typically condition on:

• Bring-down of reps: seller's reps must remain accurate as of closing, usually qualified by an MAE standard (not absolute accuracy)
• Covenant compliance: seller must have performed pre-closing covenants (ordinary course operation, no extraordinary actions)
• HSR expiration or clearance: waiting period expired or early-terminated without enforcement action
• No injunction: no court order blocking consummation
• Third-party consents: specified consents for material contracts, licenses, or regulatory transfers
• No MAE: no material adverse effect has occurred between signing and closing

Financing conditions (requiring the buyer to have financing in place) are uncommon in strategic deals and typical in sponsor deals. Financial performance conditions (requiring minimum EBITDA) are rare in strategic M&A and generally resisted by sellers.

The MAE Definition — Structure

MAE definitions follow a standard three-part structure:

1. Base definition: "any event or condition that has had or would reasonably be expected to have a material adverse effect on the business, financial condition, or results of operations of the target"
2. Carve-outs: categories of events specifically excluded from the MAE definition — even if they have material adverse effect, they don't count
3. Disproportionate effect qualifier: carve-outs don't apply if the target is affected disproportionately relative to industry peers

Standard Carve-Outs

• General economic, political, or financial market conditions
• Industry-wide changes (regulatory, demand, supply)
• Changes in applicable law or GAAP/IFRS accounting standards
• Acts of war, terrorism, or pandemic
• Failure to meet internal forecasts or analyst expectations (the underlying cause may still be MAE; the miss itself is not)
• Actions taken at buyer's written request

Disproportionate Effect

The carve-out exception: if the target is affected "disproportionately" vs. its industry peers by an otherwise-carved-out event, the carve-out doesn't protect the seller. A target whose revenues collapse 60% during a recession that cost peers 10% can still produce an MAE despite the "general economic conditions" carve-out.

Delaware's High Bar — Akorn and Beyond

Delaware courts have consistently held MAE invocations to a very high standard. Through 2018, no Delaware court had ever upheld a buyer's MAE invocation. Akorn, Inc. v. Fresenius Kabi AG (2018) was the first — the target's FDA compliance deteriorated sharply post-signing, EBITDA collapsed, and the Delaware Chancery Court allowed Fresenius to terminate. The standard remains very high: the effect must be sustained (not short-term), severe (not incremental), and endogenous (not from the buyer's own actions).

COVID-era cases tested MAE claims with mixed results — most claimants failed to meet the sustained/severe bar, and courts generally interpreted pandemic effects as falling within carve-outs.

Ordinary Course Covenants

Between signing and closing, the seller agrees to operate in the ordinary course of business — no extraordinary capex, no material contracts, no sales of material assets, no dividends or distributions, no hiring or firing key personnel without buyer consent. These covenants prevent the seller from extracting value or impairing the business during the interim period.

Termination Rights and Remedies

Every definitive agreement specifies the circumstances in which either party can walk away and the financial consequences of doing so.

Mutual Termination Rights

• Outside date (drop-dead date): if closing hasn't occurred by a specified date, either party can terminate. Typical 9-12 months for deals with significant regulatory review; 4-6 months for simpler transactions. Often extended automatically when HSR second requests are issued
• Injunction: if a non-appealable court order blocks consummation, either party can terminate
• Failure to obtain regulatory approval: in specified circumstances, either party can terminate if required regulatory approvals are denied or not obtained within a specified period

Buyer Termination Rights

• Material uncured breach by the seller of a rep or covenant
• Seller MAE (in deals with a no-MAE closing condition)
• Failure of a specific closing condition uniquely dependent on the seller

Seller Termination Rights

• Material uncured breach by the buyer of a rep or covenant
• Failure of the buyer to fund at close (subject to specific- performance mechanics)
• Seller board exercise of its "fiduciary out" to accept a superior proposal (triggers break fee)

Termination Fees

Termination fees compensate the non-terminating party for lost transaction value and the costs of pursuing an unsuccessful deal.

• Target break fee: paid by seller if the seller terminates to accept a superior proposal from a third party. Typical range 2.5–3.5% of equity value. Delaware courts scrutinize break fees that exceed that range as potentially coercive of the fiduciary process
• Reverse termination fee (RTF): paid by buyer if the buyer cannot fund (financing failure). Typical range 5–8% of equity value in sponsor deals, where RTF is often the seller's sole remedy for financing failure
• Regulatory RTF: some deals include an RTF payable by the buyer if regulatory approval fails. Sizing depends on antitrust risk at signing

Ticking Fees

When regulatory review causes extended closing delays, some DAs include a ticking fee — the purchase price increases by a specified amount per day after a "no-tick" date. The accrual compensates the seller for the time value of money. Typical structure: 0.01 per share per day, or an annualized percentage of equity value applied daily.

Specific Performance

Specific performance is a court order compelling a party to close the transaction as agreed. In strategic deals, mutual specific performance is common (either party can force close). In sponsor deals, specific performance is typically conditional:

• If debt financing is available: the seller can force closing through specific performance — preventing the sponsor from pretextually walking
• If debt financing has failed: specific performance is unavailable; seller's sole remedy is the RTF

This bifurcation allocates financing risk cleanly: the sponsor bears the deal-execution risk (and can be forced to close), but not catastrophic financing-market risk (which caps at the RTF).

Hart-Scott-Rodino Premerger Notification

The HSR Act requires parties to certain mergers and acquisitions to notify the FTC and DOJ before closing and observe a statutory waiting period during which the agencies review for potential competitive concerns. HSR is a notification regime — it does not by itself approve or prohibit a transaction.

Jurisdictional Framework — Two Tests

HSR applies when a transaction meets specified thresholds. The thresholds are adjusted annually based on changes in gross national product. For 2026:

• Size-of-transaction threshold: $133.9 million. Transactions where the buyer will hold voting securities, assets, or non-corporate interests above this amount may be reportable
• Size-of-person threshold: one party must have $267.8 million or more in annual net sales or total assets, and the other party must have $26.8 million or more. Applies only to transactions between $133.9 million and the upper threshold
• Upper size-of-transaction threshold: $535.5 million. Above this level, the size-of-person test does not apply — filing is required regardless of party size

Exact threshold values adjust each year; the framework (two-test structure, annual GNP adjustment) is stable.

Filing Fees — Tiered

The 2023 Consolidated Appropriations Act restructured HSR filing fees into six tiers scaling with transaction size. For 2026:

• Lowest tier (transactions near the size-of-transaction threshold): approximately $35,000
• Top tier (multi-billion dollar deals): approximately $2.46 million
• Fees are paid by the acquiring party at filing and are adjusted annually based on the consumer price index

The 30-Day Waiting Period

Once both parties file their HSR notifications, the agencies have 30 calendar days to review the transaction. During this period, the agencies may:

• Grant early termination (allowing the parties to close sooner) — though early termination has been suspended during some administrations and is used sparingly in current practice
• Allow the waiting period to expire without action, permitting the parties to close
• Issue a "second request" for additional information, which restarts and extends the waiting period substantially

Cash tender offers operate on a shortened 15-day initial waiting period, not the full 30.

Second Requests

A second request is a formal demand for extensive additional information — documents, data, interrogatories, economic analyses — issued when the agencies have material competitive concerns. Key features:

• Waiting period is extended until the parties have "substantially complied" with the request
• Compliance typically takes months, involving hundreds of custodians and millions of pages of documents
• After substantial compliance, the agency has an additional 30 days to take action — file suit, enter a consent decree, or allow the deal to close
• Second requests dramatically extend deal timelines and budget; most deals that receive them are restructured with divestiture commitments or other remedies

Per-Day Civil Penalty

Parties that fail to file when required, or close before the waiting period expires, face civil penalties. Current maximum: approximately $53,088 per day per party, adjusted annually.

Antitrust Substantive Review — HHI and Merger Guidelines

While HSR provides the notification framework, the substantive analysis of whether a merger lessens competition is governed by the DOJ/FTC Merger Guidelines. The guidelines were substantially revised in December 2023.

The Herfindahl-Hirschman Index (HHI)

HHI measures market concentration by summing the squares of each firm's market share in the relevant market (expressed as whole numbers). A monopoly market has HHI = 10,000 (100² = 10,000). A market with 10 equal-sized firms has HHI = 1,000 (10 × 10² = 1,000).

2023 Merger Guidelines Thresholds — TIGHTER

The 2023 Merger Guidelines (issued December 18, 2023) lowered the concentration thresholds that trigger a structural presumption of illegality:

• Highly concentrated market: post-merger HHI above 1,800 (previously 2,500 under the 2010 Horizontal Merger Guidelines)
• Structural presumption trigger: merger creates or further consolidates a highly concentrated market AND increases HHI by more than 100 points (previously 200 points)
• New 30% market share trigger: merger creating a firm with combined share above 30% AND an HHI increase above 100 points — regardless of post-merger HHI level

These thresholds are materially tighter than the 2010 Guidelines they replaced. Mergers that would have been safely below the structural presumption under 2010 rules may now face one.

Horizontal vs. Vertical Mergers

• Horizontal mergers combine direct competitors at the same level of the supply chain. Analysis focuses on market concentration (HHI) and unilateral/coordinated effects on remaining competition
• Vertical mergers combine firms at different levels of the supply chain (e.g., a steel manufacturer acquiring a downstream automotive parts maker). Analysis focuses on foreclosure risk — could the combined firm deny rivals access to critical inputs or distribution?

The 2023 Merger Guidelines express increased skepticism of vertical mergers and eliminated the 2020 Vertical Merger Guidelines (which had been rescinded by the FTC in 2021). The current framework treats some vertical integration as potentially anticompetitive where the merged firm could limit access to a product that rivals use to compete.

Remedies

When agencies identify competitive concerns, parties may negotiate remedies to secure clearance:

• Structural remedies (preferred): divestiture of specific assets, business lines, or subsidiaries to a qualified third-party buyer. Eliminates the competitive concern rather than monitoring it
• Behavioral remedies (disfavored): ongoing commitments such as licensing obligations, non-discrimination requirements, firewalls. Require agency monitoring and are viewed skeptically because they depend on compliance
• Consent decrees: the legal mechanism that embodies the negotiated remedy, filed with and enforced by a federal court

CFIUS — Foreign Investment Review

The Committee on Foreign Investment in the United States (CFIUS) is an interagency committee that reviews transactions in which a foreign person acquires an interest in a U.S. business. CFIUS focuses on national security implications, not competitive effects.

Voluntary vs. Mandatory Filings

CFIUS filings were historically voluntary. The Foreign Investment Risk Review Modernization Act (FIRRMA) — enacted in 2018 — created mandatory filing categories:

• TID U.S. businesses — those involved in critical Technologies, critical Infrastructure, or sensitive personal Data — combined with specified foreign-investor characteristics (e.g., substantial foreign government ownership) trigger mandatory filings
• Outside TID categories, filings remain voluntary

Voluntary filings remain strategically important — CFIUS has authority to review and unwind transactions post-closing if national security concerns emerge. A voluntary pre-close filing produces a "safe harbor" letter that forecloses post-close review of the filed transaction.

Review Timeline — 45 + 45 Days

After CFIUS accepts a complete notice:

• Initial review period: 45 days, during which CFIUS determines whether the transaction raises national security concerns
• Investigation period: if concerns arise, an additional 45-day investigation period is triggered. During investigation, CFIUS may negotiate mitigation with the parties
• Presidential action: if mitigation is not achievable, CFIUS can recommend to the President that the transaction be blocked or, if already closed, unwound. The President has 15 days to act on the recommendation

Mitigation Agreements

Mitigation is the most common outcome for transactions that raise concerns. Common mitigation measures:

• Passive investment limits: restrictions on the foreign investor's ability to access information or influence decisions (no board seats, limited voting rights, information walls)
• Governance restrictions: U.S.-citizen CEO and officers, U.S.-based board committee for sensitive matters
• Data security commitments: data residency requirements, access controls, third-party monitors
• Divestiture of specific operations: the sensitive business line is carved out and divested, while the rest of the transaction proceeds
• Proxy agreements: required for certain defense- sensitive acquisitions; foreign owner's voting rights are exercised by cleared U.S. proxy holders

Industry-Specific Regulatory Approvals

Regulated industries require approvals from sector-specific agencies in addition to HSR clearance. Transaction timelines and feasibility often turn on these approvals more than on antitrust.

Banking and Financial Services

• Federal Reserve approval under the Bank Holding Company Act for bank holding company mergers and acquisitions
• OCC approval for national bank mergers
• FDIC approval for insured depository institution mergers
• State banking approvals for state-chartered institutions
• Review considers financial stability, community impact (Community Reinvestment Act), managerial resources, and convenience and needs

Broadcast and Telecommunications

• FCC approval required for broadcast license transfers (TV, radio) and many telecommunications transactions
• Foreign ownership restrictions: broadcast licenses are generally subject to a 25% foreign ownership cap under Section 310(b) of the Communications Act, though this can be exceeded with FCC approval
• FCC review includes public interest determination, often producing extended timelines (12+ months) for complex transactions

Defense and Aerospace

• CFIUS review for foreign acquirers, often mandatory given TID scope
• DCSA (Defense Counterintelligence and Security Agency) approval required for transactions affecting cleared facilities under the National Industrial Security Program
• Proxy agreements or Special Security Agreements may be required when a foreign acquirer holds classified contracts — voting rights exercised by cleared U.S. proxy holders, with operational firewalls separating the foreign parent from classified work

Utilities and Energy

• FERC approval under Section 203 of the Federal Power Act for public utility mergers affecting electric transmission
• State public utility commissions for retail utility acquisitions, which may impose rate-cap or service commitments
• NRC approval for nuclear facility transfers

Healthcare

State attorneys general scrutinize hospital mergers; some states require prior approval. The FTC has devoted increasing resources to healthcare merger enforcement, particularly hospital system consolidation. Certain acquisitions of healthcare data companies also trigger CFIUS TID review under sensitive personal data.

Timeline Implication

Regulated-industry deals often carry outside dates of 12-18 months (vs. 6-9 months for unregulated transactions) because sector-specific reviews can extend well beyond HSR. Buyers should calendar approval timelines early and build contingency into the definitive agreement.

Hostile Acquisition Tactics

When a target's board rejects a negotiated approach or refuses to engage, acquirers can pursue the target through public pressure, direct-to-shareholder tactics, or stock accumulation — subject to a lattice of SEC rules governing each approach.

Bear Hug Letters

A bear hug is a public (or semi-public) unsolicited offer letter from the acquirer to the target's board, typically at a significant premium to the unaffected stock price. The tactic is pressure, not procedure:

• Once shareholders know a specific premium offer is available, the board's refusal to engage becomes harder to defend
• Activist investors often mobilize around a public bear hug, amplifying pressure on the board
• Bear hugs do not by themselves trigger Williams Act obligations (those require a formal tender offer) or activate the target's poison pill

Schedule 13D — 5 Business Days

Any person acquiring more than 5% of a public company's voting stock with intent to influence control must file Schedule 13D. The deadline was shortened effective February 5, 2024:

• Initial 13D filing: due within 5 business days of crossing 5% (formerly 10 calendar days)
• Amendments to 13D: due within 2 business days of a material change (formerly "promptly")
• Passive investors (no control intent) may file the shorter Schedule 13G with later deadlines

The shortened window gives activists less runway to accumulate stock quietly before disclosure reveals their position to the market.

Toeholds

A toehold is a minority stock position accumulated by a potential acquirer before launching a formal bid. Typically kept below 5% to avoid triggering Schedule 13D disclosure, toeholds provide:

• Lower average cost of the eventual acquisition
• Consolation profits from appreciation if a competing bidder emerges and raises the price

Toeholds are less common in current U.S. practice than historically because of disclosure acceleration, market efficiency, and insider- trading concerns. They remain more common in European jurisdictions.

Creeping Tender Offers and the Williams Act

The Williams Act regulates formal tender offers, imposing minimum offer periods, pro-rata treatment, all-holders/best-price rules, and disclosure requirements. A creeping tender offer is gradual open-market accumulation that courts may recharacterize as a tender offer under the Wellman factors test:

1. Active and widespread solicitation of public shareholders
2. Solicitation for a substantial percentage of the target's stock
3. Offer at a premium to market
4. Firm (rather than negotiable) terms
5. Conditioned on a minimum number of shares tendered
6. Offer open only for a limited time
7. Pressure on sellers to tender
8. Public announcements preceding accumulation

If a court applies these factors and finds a tender offer in substance, Williams Act procedural protections must be observed. Random unsolicited open-market purchases without these characteristics generally do not trigger Williams Act treatment.

Poison Pill Mechanics — Flip-In and Flip-Over

The prior course content introduces shareholder rights plans ("poison pills") at a surface level. This section drills into the specific mechanics tested in advanced questions.

Flip-In Pills

Flip-in is the dominant pill structure. Mechanics:

• Trigger: when a hostile acquirer crosses a specified ownership threshold — typically 10%, sometimes 15% or 20% — without board approval
• Effect: all shareholders other than the triggering acquirer receive the right to purchase additional target shares at a substantial discount — typically 50% off market
• Result: exercise by other shareholders dramatically dilutes the acquirer's percentage ownership. The acquirer is effectively locked out of completing the hostile acquisition at economically rational terms

Example: an acquirer accumulates 11% of target stock at $40/share. Pill triggers at 10%. Other shareholders can now buy target shares at $20 (50% discount). If they exercise aggressively, the acquirer's 11% might dilute to 3-4% — making the hostile takeover mathematically impractical. The acquirer must negotiate with the board to have the pill redeemed (canceled) before proceeding.

Flip-Over Pills

Flip-over provisions operate at a different point in the timeline:

• Trigger: the acquirer completes a subsequent business combination (e.g., second-step merger) with the target
• Effect: target shareholders' rights "flip over" into the acquirer's stock, entitling them to buy acquirer shares at a steep discount
• Result: dilution at the acquirer level if the acquirer forces a merger

Modern Pills — Combined Flip-In + Flip-Over

Current poison pills typically combine both features: flip-in dilutes the acquirer's target ownership at the initial triggering event, and flip-over dilutes the acquirer's own stock if it subsequently forces a merger. The two-layer defense creates incentives for the acquirer to negotiate at both stages.

Redemption and Negotiation

The target board retains the right to redeem (cancel) the pill before it triggers, typically for a nominal price. This redemption right is what makes pills compatible with the board's fiduciary duty: the pill is a bargaining tool, not an absolute veto. A board that would not redeem even for a bona fide premium offer risks breaching its fiduciary duties under Unocal and Revlon doctrine.

Structural Defenses Beyond the Poison Pill

Pills are defensive, redeemable, and ad hoc. Structural defenses are embedded in the charter, bylaws, or operating structure — harder to remove and slower to overcome.

Staggered (Classified) Boards

Under a classified board structure, directors are divided into three classes serving three-year terms, with one class standing for election each year. Consequences for hostile acquirers:

• A proxy contest to replace a board majority requires winning two consecutive annual elections — typically an 18-24 month campaign
• Combined with a poison pill, a staggered board effectively forces negotiation: the acquirer cannot simultaneously pressure the board via ownership and replace the board via elections before the pill dilutes the stake
• Institutional shareholders increasingly press for declassification; large-cap S&P 500 companies have largely abandoned staggered boards, while smaller-cap and newly-public companies retain them more frequently

Supermajority Voting Provisions

Charter provisions requiring supermajority shareholder votes (often 66.67%, 75%, or 80%) to approve mergers not recommended by the board make hostile acquisitions mathematically difficult:

• An acquirer with bare majority support still cannot force a merger without crossing the supermajority threshold
• Combined with a staggered board, the acquirer must first win multiple election cycles to install a cooperative board that can recommend the deal — triggering the lower voting threshold
• Delaware courts generally uphold supermajority provisions as within a board's business judgment

NOL Poison Pills — The 4.99% Trigger

NOL pills use a much lower ownership threshold (typically 4.99%) than standard pills. The purpose is not takeover defense per se but preservation of net operating loss carryforwards under Section 382:

• Recall from Pass 1: a Section 382 "ownership change" occurs when 5% shareholders' cumulative ownership shifts by more than 50 percentage points over three years
• By preventing any shareholder from crossing the 5% threshold, an NOL pill blocks new 5% shareholders from entering the Section 382 calculation — protecting NOL value
• NOL pills are common at companies with substantial NOLs and are generally viewed as a legitimate tax-planning tool rather than an anti-takeover device

Dead-Hand and No-Hand Pills

Dead-hand pills restrict redemption rights to "continuing directors" — those who were on the board before the triggering event — making it harder for an acquirer to replace the board and then redeem the pill. No-hand variants go further, preventing redemption for a specified period (e.g., 180 days) even by continuing directors.

Both structures have been found unenforceable under Delaware law (Carmody v. Toll Brothers, Quickturn v. Shapiro) because they impermissibly restrict the board's ability to manage the company. They remain available in some other jurisdictions but are rare in modern U.S. practice.

Proxy Contests — Mechanics and Rules

When negotiation fails and a hostile tender offer is impractical, the acquirer can pursue a proxy contest — competing with the incumbent board for shareholder votes to replace directors who will then take actions favorable to the acquirer (e.g., redeeming the pill, approving a merger).

Schedule 14A Filing

Any person soliciting proxies must file a definitive proxy statement on Schedule 14A with the SEC, containing:

• Identity of participants in the solicitation and their direct or indirect interests
• Description of the matters to be acted upon
• Nominees for any contested director positions
• Description of the soliciting party's plans for the target
• Information about shares held, transactions in target stock, and any arrangements with other participants

Advance-Notice Bylaws

Target companies typically have bylaws requiring shareholders to submit director nominations within a specified window before the annual meeting:

• Typical windows: 90 to 120 days before the anniversary of the prior year's annual meeting
• Failure to comply forecloses the nomination; courts strictly enforce advance-notice provisions absent unusual circumstances
• Advance-notice bylaws are among the most consequential procedural defenses — missing the window ends the contest before it begins

Rule 14a-12 — Early Solicitation

Rule 14a-12 permits solicitation before a definitive proxy statement is furnished, provided certain conditions are met:

• Soliciting materials must identify participants or include a prominent legend directing shareholders to participant information
• A prominent legend must advise shareholders to read the proxy statement when available
• All soliciting materials must be filed with the SEC on or before first use

Rule 14a-12 allows activists to build their narrative through press releases, investor letters, and public commentary before the formal proxy statement is delivered — a significant practical tool in modern contests.

Rule 14a-19 — The Universal Proxy Rule

Effective September 1, 2022, Rule 14a-19 requires universal proxy cards in contested director elections at public companies:

• Both the dissident and the incumbent must include the names of all duly-nominated candidates from both sides on their proxy cards
• Shareholders can pick and choose across slates rather than being forced to vote an entire dissident or entire incumbent slate
• The dissident must notify the registrant of its nominees within specified windows and solicit holders of at least 67% of voting power

The universal proxy rule is the most significant change to proxy contest mechanics in decades. It arguably helps dissidents (who can now offer a la carte slates that appeal to shareholders unwilling to reject every incumbent director) but also imposes disclosure and solicitation obligations that increase contest cost.

Distinguishing Proxy Rules from Tender Offer Rules

A common source of confusion: proxy contests and tender offers are governed by different rule sets. Proxy contests fall under the 14a-series rules (Schedule 14A, Rule 14a-12, Rule 14a-19). Tender offers fall under the Williams Act and associated 13d, 13e, 14d, and 14e rules — including the all-holders/best-price rule under Rule 14d-10, which applies to tender offers only. An acquirer running a proxy contest without a concurrent tender offer is not subject to all-holders/best-price requirements on its share purchases during the contest.

Buy-Side Advisor Engagement — Fee Structure and Tail

The buy-side engagement letter is the contract between the buyer and its investment banking advisor. Its structure affects advisor incentives, client protections, and residual exposure if the deal falls apart.

Standard Fee Structure

A typical buy-side engagement includes three fee components:

• Monthly retainer: $50,000–$200,000 per month for middle-market deals, larger for complex mandates. Ensures the bank is compensated for work performed even if the deal does not close. Often creditable against the success fee (deducted from success fee at close) or non-creditable (stacked on top)
• Success fee: payable only on closing. Typically calculated as a percentage of transaction value on a declining scale — e.g., 1.0% on the first $500M, 0.75% on the next $500M, 0.5% above $1B. Larger deals produce lower blended rates
• Expense reimbursement: out-of-pocket expenses (travel, external DD vendors, data services) reimbursed separately, typically with a cap requiring client approval above a threshold

Hourly billing is unusual in M&A advisory. Performance- or synergy-based fees are rare.

Tail Period Provisions

The tail protects the advisor from being disintermediated. Core mechanic:

• If the client closes a transaction with a party identified, introduced, or contacted by the advisor during the engagement, within the tail period after termination, the success fee is still earned
• Typical tail period: 12 to 24 months after engagement termination
• Scope: parties named in a written "introduction list" the advisor maintains during the engagement, or more broadly parties the advisor substantively engaged with

Without a tail, a client could fire the advisor just before closing — after the advisor has done the work to identify and engage the counterparty — to avoid paying the success fee. The tail makes that end-run unprofitable for the client.

Fairness Committee Process

For deals where the bank will issue a fairness opinion, the engagement letter typically describes the internal fairness committee process the bank will follow. FINRA Rule 5150 requires:

• Written procedures for fairness opinion review
• Selection of committee members
• Member qualifications (balanced perspectives from different transaction types, seniority levels, and geographies)
• Review of the valuation approach and conclusions by someone not on the deal team

The fairness committee serves as a defense against litigation risk and a check on deal-team valuation work.

Deal Tactics — Auction vs. Negotiated, Pre-emptive Bids

Auction Process Mechanics

A seller-run auction proceeds in phases, with bidders narrowing at each stage:

• Teaser and CIM: one-page teaser identifies the opportunity; confidentiality agreement signed; Confidential Information Memorandum (CIM) provides detailed business overview
• Indication of Interest (IOI): non-binding preliminary bid with valuation range, financing approach, key assumptions. Typically submitted by 8-15 bidders
• Letter of Intent (LOI): more detailed bid after VDR access and management meetings. Usually 4-6 bidders
• Binding final bid: after confirmatory DD and DA markup. 1-3 bidders, with a preferred bidder selected for exclusivity
• Exclusivity and signing: 30-60 day exclusive window for final DD and DA negotiation

Buy-Side Tactics in Auctions

Advancing through rounds requires tactical judgment:

• Early rounds: bid high enough to advance to the next stage, without burning all negotiating leverage. A "maximum" IOI leaves no room to chip price in later rounds
• Exclusivity round: final binding bid is the critical number. Advisors often push bidders to "bid to win" (their maximum value) on price while securing favorable non- price terms (indemnification, R&W insurance, closing conditions) during DA negotiation
• Non-price differentiation: when price is competitive, non-price terms — closing certainty, speed, no financing condition, favorable regulatory risk allocation — can tip the seller's choice

Pre-Emptive Bids

A pre-emptive bid is a full-value offer made before (or early in) a planned auction, designed to convince the seller to sign bilaterally rather than expose the deal to competition. Mechanics:

• Bid is typically above what the bidder would pay in a blind auction — the premium buys transaction certainty and avoids the competitive dynamic
• Sellers accept pre-empts only when the bid meaningfully exceeds expected auction value, because running an auction typically improves price
• Bidder strategy: identify the seller's reserve price early, make an offer the seller cannot responsibly refuse, and demand exclusivity immediately

Board Presentation — Strategic Rationale

When the banker presents a proposed acquisition to the buyer's board, the presentation organizes around:

• Strategic fit: why this target, why now, why this buyer
• Synergies: quantified revenue, cost, and financial synergies with explicit phasing and discount for revenue synergies
• Valuation framework: DCF, precedent transactions, trading multiples, LBO analysis if relevant; converge on a recommended price range
• Financing structure: sources of funds, pro forma leverage, credit implications, cost of capital effect
• Key DD findings and risks: material red flags and how they're addressed in deal terms
• Post-close integration plan: who leads, key milestones, synergy tracking methodology

Exhaustive historical deep-dives, peer-choice analyses, or personal philosophy are not the board's decision framework. The board needs a clear, concise, decision-ready narrative with supporting analysis on standby.

Going-Private Transactions and Management Buyouts

When a public company is taken private — often by its own management team, a private equity sponsor, or a controlling shareholder — transactions face enhanced disclosure and heightened fiduciary scrutiny because the transaction parties sit on both sides of the deal.

Rule 13e-3 Disclosure

Rule 13e-3 under the Exchange Act applies to going-private transactions where an affiliate of the issuer acquires the remaining public stock. Key requirements:

• Enhanced disclosure in the proxy statement or tender offer materials — including detailed fairness discussion, valuation methodology, purpose of the transaction, and alternatives considered
• Schedule 13E-3 filing with the SEC containing this enhanced disclosure
• Director fairness determinations — each director must state whether they believe the transaction is fair to unaffiliated shareholders, with reasons

Special Committee — The Core Structural Response

The governance response to conflicts in going-private transactions is the special committee of independent directors:

• Composed entirely of directors with no relationships to the controlling shareholder, management buyer, or sponsor
• Advised by independently selected financial and legal advisors (not carried over from the company's usual advisors if those have conflicts)
• Empowered to negotiate at arm's length with the controller/buyer — including the right to say no and the power to run a market check for alternative proposals
• Often empowered with "deal blocking" authority — the controller cannot proceed without committee approval

MFW — Business Judgment Rule via Dual Protections

The Delaware Supreme Court's decision in Kahn v. M&F Worldwide Corp. (2014) — known as MFW — established the framework for shifting the judicial review standard in controller going-private transactions from entire fairness to the deferential business judgment rule:

• The transaction is conditioned ab initio (from the start) on approval by an independent special committee
• The transaction is also conditioned ab initio on an informed, uncoerced majority-of-the-minority vote (a majority of unaffiliated shareholders must approve)
• Both conditions are non-waivable — the controller cannot abandon either if the process unfolds
• The committee is truly independent, properly empowered, and meets its duty of care in negotiation

When all elements are satisfied, entire fairness review (which places the burden on defendants to prove fair price and fair dealing) gives way to business judgment review (which presumes director action is proper). The practical effect: MFW-compliant transactions are much harder to challenge successfully.

Management Buyouts — Conflict at Its Sharpest

In a management buyout, the target's CEO, CFO, and key executives partner with a financial sponsor to acquire the company. The conflict is structural:

• Management knows more about the business than any outside bidder — information asymmetry favors them in price negotiations
• Management controls the flow of information to other potential bidders through the sale process
• Management has incentives to support a lower purchase price (they buy in cheaper) while their fiduciary duty is to maximize shareholder value (they should drive price up)

Governance responses to MBOs include:

• A robust independent special committee (no management directors) empowered to run the sale process
• Restricted management communication with competing bidders — information goes through the committee's advisors
• Thorough market-check process — active solicitation of competing offers, often including a post-signing go-shop period during which the target can actively solicit superior proposals
• Enhanced disclosure of management's post-close arrangements (equity rollover, retention bonuses, employment agreements) so shareholders can evaluate conflicts

Cross-Border Acquisitions — Additional Dimensions

Cross-border deals add several dimensions absent from domestic transactions. These issues materially affect deal economics and are routinely addressed in bid structure and post-closing tax planning.

Currency Risk and Hedging

Between signing and closing, currency movements can materially change the dollar-equivalent purchase price:

• A U.S. buyer acquiring a European target for €500M at a $1.10 exchange rate owes $550M. If the euro strengthens to $1.20 by closing, the cost becomes $600M — a 9% increase unrelated to the target's business
• Standard hedging: forward contracts or currency options locked in at signing to fix the dollar cost of the closing payment
• Option-based hedging carries premium cost but preserves benefit from favorable currency movements
• Forward-based hedging has no upfront cost but eliminates both upside and downside

Withholding Tax on Dividends

After acquisition, the U.S. parent typically wants to repatriate cash from the foreign subsidiary via dividends. Source-country withholding tax can be substantial:

• Many countries apply 25-30% withholding on dividends paid to foreign parents absent treaty reductions
• Tax treaties between the U.S. and specific countries often reduce the rate to 5%, 10%, or 15% depending on ownership percentage and holding period requirements

Tax Treaty Analysis and Holding Company Structures

Sophisticated cross-border structures route ownership through intermediate holding companies in favorable treaty jurisdictions:

• Example: U.S. parent → Netherlands holding company → target. The Netherlands has extensive treaty networks reducing withholding rates; the U.S.-Netherlands treaty may further reduce the rate from target to Netherlands holding
• Anti-treaty-shopping provisions: most modern treaties include "limitation on benefits" articles requiring substantial business activity in the treaty country, not merely paper presence
• GILTI (Global Intangible Low-Taxed Income): U.S. tax reform (2017) introduced current-period taxation of certain foreign subsidiary income, changing the calculus of long-term deferral strategies

Other Cross-Border Considerations

• Foreign regulatory approvals: merger control regimes in EU (European Commission), UK (CMA), China (SAMR), Brazil (CADE), and others. Parallel filings and approvals can extend timelines significantly
• Local employment law: European jurisdictions often require works council consultation before deal announcement; failure to consult can produce legal claims
• Language and document translation: disclosure schedules, contracts, and regulatory filings may need formal translation
• Local counsel coordination: sophisticated buyers maintain a lead counsel in the buyer's jurisdiction coordinating local counsel in each relevant jurisdiction

Cross-border deals are NOT exempt from U.S. antitrust — HSR applies based on U.S. commerce effects, and CFIUS applies to foreign acquirers of U.S. businesses. U.S. banks routinely finance cross-border transactions.